Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-18 Burns John Thomas CFO Sale −3,831 $19.18 $73K 558,893
2026-11-18 CICIC DRAGAN SVP, Chief Development Officer Sale −6,933 $19.18 $133K 557,361
2026-11-18 Stergiou Angelos M. President and CEO Sale −26,606 $19.18 $510K 1,734,896
2026-06-16 Stergiou Angelos M. President and CEO Grant or award +1,065,000 1,759,183
2026-01-07 Varian John Director Grant or award +50,000 72,900
2026-01-07 VAN NOSTRAND ROBERT L Director Grant or award +50,000 82,900
2026-01-07 SCHEINBERG DAVID A Director Grant or award +50,000 73,082
2026-01-07 CICIC DRAGAN SVP, Chief Development Officer Grant or award +300,000 557,805
2026-01-07 Burns John Thomas CFO Grant or award +300,000 554,327
2026-01-07 Kalin Katherine Bach Director Grant or award +50,000 154,400
2026-01-07 Wasman Jane Director Grant or award +50,000 92,900
2025-12-03 CICIC DRAGAN SVP, Chief Development Officer Other disposition −63,800 $1.50 $96K 257,805
2025-12-03 Burns John Thomas CFO Other disposition −58,592 $1.50 $88K 254,327
2025-12-03 Stergiou Angelos M. President and CEO Other disposition −187,066 $1.50 $281K 686,966
2025-11-19 Kalin Katherine Bach Director Purchase +63,400 $1.59 $101K 104,400
2025-06-12 VAN NOSTRAND ROBERT L Director Purchase +10,000 $1.48 $15K 20,400
2025-05-30 Wasman Jane Director Purchase +20,000 $1.69 $34K 30,400
2025-05-22 Kalin Katherine Bach Director Purchase +20,000 $1.80 $36K 41,000
2025-01-10 Burns John Thomas CFO Grant or award +113,000 217,762
2025-01-10 Burns John Thomas CFO Grant or award +81,300 299,062

Page 1 of 29 · 580 trades